, nécessité de recours à l'hémodialyse et à la ventilation mécanique ainsi que l'absence de plasmaphérèse sont les facteurs pronostiques associés au décès chez les patients anti-MBG
Landmark publication from The American Journal of the Medical Sciences: The significance of certain pulmonary lesions in relation to the etiology of influenza, Am J Med Sci. août, vol.338, issue.2, pp.148-51, 2009. ,
Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis), Australas Ann Med. mai, vol.7, issue.2, pp.132-176, 1958. ,
Immune Aspects of the Glomerulonephritis Associated with Pulmonary Hemmorhage, Annals of Internal Medicine. 1 juin, vol.60, issue.6, p.1009, 1964. ,
The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis, J Exp Med. 1 déc, vol.126, issue.6, pp.989-1004, 1967. ,
, revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, vol.65, pp.1-11, 2012.
A collagen of unusual composition and a glycoprotein isolated from canine glomerular basement membrane, Biochem Biophys Res Commun. 4 janv, vol.22, issue.1, pp.26-32, 1966. ,
Alport's syndrome, Goodpasture's syndrome, and type IV collagen, N Engl J Med. 19 juin, vol.348, issue.25, pp.2543-56, 2003. ,
Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV, J Biol Chem. 15 sept, vol.263, issue.26, pp.13374-80, 1988. ,
The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain, J Biol Chem. 16 avr, vol.274, issue.16, pp.11267-74, 1999. ,
,
, Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis, N Engl J Med. 22 juill, vol.363, issue.4, pp.343-54, 2010.
Glomerulonephritis induced in sheep by injections of heterologous glomerular basement membrane and Freund's complete adjuvant, J Exp Med. 1 août, vol.116, pp.253-72, 1962. ,
Antigen restriction and IgG subclasses among anti-GBM autoantibodies, Nephrol Dial Transplant, vol.5, issue.12, pp.991-997, 1990. ,
The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity, Hum Immunol. juin, vol.70, issue.6, pp.425-434, 2009. ,
Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity, Clin Immunol. juill, vol.116, issue.1, pp.77-82, 2005. ,
Anti-glomerular basement membrane antibody-induced glomerulonephritis, Kidney Int. févr, vol.3, issue.2, pp.74-89, 1973. ,
Recurrent Goodpasture's disease, Am J Kidney Dis. avr, vol.27, issue.4, pp.573-581, 1996. ,
Recurrent glomerulonephritis after kidney transplantation, Am J Transplant. nov, vol.6, issue.11, pp.2535-2577, 2006. ,
,
, Intraglomerular T cells and monocytes in nephritis: study with monoclonal antibodies, Kidney Int. mai, vol.31, issue.5, pp.1160-1166, 1987.
,
, Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury, Kidney Int. févr, vol.67, issue.2, pp.566-75, 2005.
CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis, J Clin Invest. févr, vol.109, issue.4, pp.517-541, 2002. ,
Healthy individuals have Goodpasture autoantigen-reactive T cells, J Am Soc Nephrol. févr, vol.19, issue.2, pp.396-404, 2008. ,
Analysis of T cell responses to the autoantigen in Goodpasture's disease, Clin Exp Immunol. mai, vol.100, issue.2, pp.262-270, 1995. ,
,
, Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease, J Am Soc Nephrol, vol.22, issue.10, pp.1946-52, 2011.
Anti-glomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy, Am J Kidney Dis. janv, vol.33, issue.1, pp.128-160, 1999. ,
Anti-glomerularbasement-membrane disease after lithotripsy, Lancet. 7 avr, vol.335, issue.8693, pp.856-863, 1990. ,
,
, Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int, vol.64, pp.1685-94, 2003.
,
, Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1, J Am Soc Nephrol. sept, vol.12, issue.9, pp.1908-1923, 2001.
,
, Spatial and Temporal Clustering of Anti-Glomerular Basement Membrane Disease, Clin J Am Soc Nephrol. 8 août, vol.11, issue.8, pp.1392-1401, 2016.
Glomerulonephritis mediated by antibody to glomerular basement membrane. Immunological, clinical, and histopathological characteristics, J Clin Invest. févr, vol.57, issue.2, pp.351-61, 1976. ,
Anti-glomerular basement membrane disease in Auckland, Intern Med J. juin, vol.42, issue.6, pp.672-678, 2012. ,
Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan, Clin Exp Nephrol, vol.12, issue.5, pp.339-386, 2008. ,
Incidence and outcome of antiglomerular basement membrane disease in Chinese, Nephrology ,
Anti-glomerular basement membrane disease, Kidney Int, vol.64, issue.4, pp.1535-50, 2003. ,
A 25-year experience with pediatric anti-glomerular basement membrane disease, Pediatr Nephrol. janv, vol.26, issue.1, pp.85-91, 2011. ,
Clinical features and outcomes of antiglomerular basement membrane disease in older patients, Am J Kidney Dis. avr, vol.57, issue.4, pp.575-82, 2011. ,
Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study, Medicine (Baltimore). sept, vol.90, issue.5, pp.303-314, 2011. ,
Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4, Br Med J (Clin Res Ed). 1 févr, vol.292, issue.6516, pp.301-305, 1986. ,
Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases, Am J Clin Pathol. mars, vol.125, issue.3, pp.445-50, 2006. ,
,
, Goodpasture's syndrome clinical and immunological studies, Nephron, vol.13, issue.2, pp.161-73, 1974.
Goodpasture's syndrome associated with influenza A2 virus infection, Ann Intern Med. janv, vol.76, issue.1, pp.91-95, 1972. ,
Fever and prodromal infections in anti-glomerular basement membrane disease, Nephrology (Carlton). mai, vol.23, issue.5, pp.476-82, 2018. ,
Anti-glomerular basement membrane disease after alemtuzumab, N Engl J Med. 14 août, vol.359, issue.7, pp.768-777, 2008. ,
Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes, Kidney Int. janv, vol.51, issue.1, pp.222-231, 1997. ,
The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease, Clin Immunol, vol.133, issue.2, pp.245-50, 2009. ,
Copy number variation of FCGR3A ,
, rather than FCGR3B and FCGR2B is associated with susceptibility to anti-GBM disease, Int Immunol. janv, vol.22, issue.1, pp.45-51, 2010.
Patients with Goodpasture's disease have two normal COL4A3 alleles encoding the NC1 domain of the type IV collagen alpha 3 chain, Nephrol Dial Transplant. août, vol.19, issue.8, pp.2030-2035, 2004. ,
,
, Goodpasture's syndrome: a clinical update, Autoimmun Rev. mars, vol.14, issue.3, pp.246-53, 2015.
Goodpasture's disease: a report of ten cases and a review of the literature, Autoimmun Rev. sept, vol.12, issue.11, pp.1101-1109, 2013. ,
,
, Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases, Medicine (Baltimore). mai, vol.86, issue.3, pp.181-93, 2007.
Rapidly progressive crescentic glomerulonephritis, Kidney Int. mars, vol.63, issue.3, pp.1164-77, 2003. ,
Anti-glomerular basement membrane disease, J Am Soc Nephrol. nov, vol.10, issue.11, pp.2446-53, 1999. ,
Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course, Nephron, vol.59, issue.2, pp.206-218, 1991. ,
,
, Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease, Kidney Int. mars, vol.83, issue.3, pp.503-513, 2013.
Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression ,
, Ann Intern Med. 5 juin, vol.134, issue.11, pp.1033-1075, 2001.
Crescentic glomerulonephritis, Nephrol Dial Transplant, vol.16, issue.6, pp.80-82, 2001. ,
Incidence and features of dual anti-GBMpositive and ANCA-positive patients. Nephrology (Carlton), vol.16, pp.725-734, 2011. ,
Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis, Kidney Int. mars, vol.37, issue.3, pp.965-70, 1990. ,
Sequential development of anti-GBM nephritis and ANCA-associated Pauci-immune glomerulonephritis, Am J Kidney Dis. août, vol.34, issue.2, pp.344-352, 1999. ,
,
, GBM antibodies in sera with or without ANCA, J Am Soc Nephrol. mars, vol.8, issue.3, pp.376-85, 1997.
Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease, Clin J Am Soc Nephrol. 7 avr, vol.11, issue.4, pp.568-75, 2016. ,
Clinical features and outcome of patients with both ANCA and anti-GBM antibodies, Kidney Int, vol.66, issue.4, pp.1535-1575, 2004. ,
,
, Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease, Clin Nephrol. sept, vol.36, issue.3, pp.107-120, 1991.
Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort ,
, Nephrol Dial Transplant. mai, vol.30, issue.5, pp.814-835, 2015.
,
, Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients, Kidney Int, vol.92, issue.3, pp.693-702, 2017.
,
, Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome, Lancet. 3 avr, vol.1, issue.7962, pp.711-716, 1976.
Plasma exchange in Goodpasture's syndrome, Am J Nephrol, vol.2, issue.6, pp.301-312, 1982. ,
,
, Outcomes of patients with Goodpasture syndrome: A nationwide cohort-based study from the French Society of Hemapheresis, J Autoimmun, vol.73, pp.24-33, 2016.
,
, Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption, PLoS ONE, vol.9, issue.7, p.103568, 2014.
Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis, BMC Nephrol. 3 août, vol.15, p.128, 2014. ,
,
, Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial, Ann Intern Med. 19 mai, vol.150, issue.10, pp.670-80, 2009.
Rituximab in anti-GBM disease: A retrospective study of 8 patients, J Autoimmun. juin, vol.60, pp.74-83, 2015. ,
Severe adult respiratory distress syndrome from Goodpasture syndrome. Survival using extracorporeal membrane oxygenation, Am J Respir Crit Care Med. 15 janv, vol.191, issue.2, pp.228-237, 2015. ,
Prolonged venovenous extracorporeal membrane oxygenation without anticoagulation: a case of Goodpasture syndrome-related pulmonary haemorrhage, Crit Care Resusc. mars, vol.16, issue.1, pp.69-72, 2014. ,
,
, Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen, Am J Kidney Dis. févr, vol.45, issue.2, pp.397-406, 2005.
The chest X-ray in antiglomerular basement membrane antibody disease (Goodpasture's syndrome), Clin Radiol. juill, vol.30, issue.4, pp.419-448, 1979. ,
Recurrent Goodpasture's syndrome, Can Med Assoc J, vol.129, issue.9, pp.978-987, 1983. ,
Characteristics and outcome of antiglomerular basement membrane disease: a single-center experience, Ren Fail. janv, vol.18, issue.1, pp.105-117, 1996. ,
,
, Recurrent Goodpasture's disease due to a monoclonal IgA-kappa circulating antibody, Am J Kidney Dis. sept, vol.34, issue.3, pp.549-55, 1999.
Recurrence of circulating antiglomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange, Clin Nephrol. avr, vol.21, issue.4, pp.244-250, 1984. ,
Goodpasture syndrome involving overlap with Wegener's granulomatosis and anti-glomerular basement membrane disease, J Am Soc Nephrol, vol.8, issue.11, pp.1795-800, 1997. ,
Goodpasture's syndrome: recurrence after a five-year remission. Case report and review of the literature, Am J Med. avr, vol.84, issue.4, pp.751-756, 1988. ,
Chronic recurrent Goodpasture's syndrome, Am J Med. avr, vol.82, issue.4, pp.833-838, 1987. ,
Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection, Br Med J. 17 sept, vol.2, issue.6089, pp.723-729, 1977. ,
Immunoadsorption in Goodpasture's syndrome, Am J Kidney Dis. août, vol.36, issue.2, pp.392-397, 2000. ,
Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association, Nephrol Dial Transplant. mars, vol.14, issue.3, pp.570-575, 1999. ,
, Am J Med. sept, vol.37, pp.424-468, 1964.
Goodpasture's syndrome. A report of five cases and review of the literature, Am J Med. févr, vol.48, issue.2, pp.162-73, 1970. ,
Anti-Glomerular Basement Membrane Disease, Clin J Am Soc Nephrol. 7 juill, vol.12, issue.7, pp.1162-72, 2017. ,
Rituximab or azathioprine maintenance in ANCA-associated vasculitis, N Engl J Med, vol.22, issue.4, pp.386-393, 2015. ,
, Regression Modeling Strategies -With Applications to Linear Models, Logistic
,
,
,
, Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by « autoantigen complementarity, J Autoimmun. mai, vol.59, pp.8-18, 2015.
Rituximab versus cyclophosphamide for ANCA-associated vasculitis, N Engl J Med. 15 juill, vol.363, issue.3, pp.221-253, 2010. ,
Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients, Rheumatology (Oxford). mars, vol.53, issue.3, pp.532-541, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01064298
,
, Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis, N Engl J Med, vol.371, pp.1771-80, 2014.
,
, Rituximab in anti-glomerular basement membrane disease, QJM. févr, vol.105, issue.2, pp.195-202, 2012.
Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN, J Am Soc Nephrol, vol.25, issue.10, pp.2291-302, 2014. ,
Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression, Kidney Int. juill, vol.88, issue.1, pp.52-60, 2015. ,
Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes, Nephrol Dial Transplant. août, vol.25, issue.8, pp.2479-86, 2010. ,